There were comparable levels of degranulation in the OVA257-264-specific CD8+ T cells between NAFLD and normal livers with OVAlow or OVAhigh tumors (Figures 3E and S2D). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.